The market share for Zubsolv was slightly lower in December 2017 (four weeks rolling average) compared to previous month. Zubsolv prescription reached a market share of 4.93% in December and measured in quantity, the market share reached 5.12%. The underlying market continues to show steady growth, with a growth rate of 8.7% for prescriptions and of 7.0% in quantity.